BSECompany Update3d ago · 28 Jul 2026, 07:53 pm
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, We wish to inform you that the Company has arranged ....
Concord Biotech Ltd · 543960
✦ AI SummaryResults
Concord Biotech Ltd has arranged an earnings call to discuss its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, scheduled on August 3, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation